Does long-acting injectable neuroleptic protect against tardive dyskinesia?
D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003692:Delayed-Action Preparations; D004409:Dyskinesia, Drug-Induced / Q000517:prevention & control*; D006801:Humans; D008297:Male
D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations